The role of Notch1 in ovarian cancer was first studied by Hopfer et al., [87] who evaluated mRNA expression of Notch pathway members in ovarian adenocarcinomas, borderline tumors and adenomas and demonstrated more frequent expression of Jag2 and DLL1 in adenocarcinomas as compared to adenomas. The gene discussed is JAG2; the disease is ovarian carcinoma.